Artera
Signal active
Organization
Contact Information
Overview
Artera is a provider of precision medicine and develops artificial intelligence (AI) testing to customize treatments for cancer patients. It develops specialized tools to support personalized clinical care. Its test predicts therapeutic benefits and provides risk stratification.
About
Industries
Biotechnology, Artificial Intelligence (AI), Life Science, Health Care, Precision Medicine
Founded
2021
Employees
101-250
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Artera headquartered in United States, North America, operates in the Biotechnology, Artificial Intelligence (AI), Life Science, Health Care, Precision Medicine sector. The company focuses on Biotechnology and has secured $4.4B in funding across 40 round(s). With a team of 101-250 employees, Artera is actively contributing to advancements in Biotechnology. Their latest funding round, Venture Round - Artera, raised $20.0M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
2
Investors
9
Lead Investors
0
Total Funding Amount
$110.0M
Details
0
Artera has raised a total of $110.0M in funding over 0 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|
Investors
Artera is funded by 31 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Rajiv Khemani | - | FUNDING ROUND - Rajiv Khemani | 20.0M |
| Trium | - | FUNDING ROUND - Trium | 20.0M |
| Artera | - | FUNDING ROUND - Artera | 20.0M |
| Andrew Tan | - | FUNDING ROUND - Andrew Tan | 20.0M |
Recent Activity
There is no recent news or activity for this profile.